Cite

HARVARD Citation

    Desideri, I. et al. (n.d.). EP-1087: Real-world Cetuximab toxicity in curative and recurrent/metastatic setting in HNSCC patients. Radiotherapy and oncology. pp. S597-S598. [Online]. 
  
Back to record